Navigation Links
The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
Date:2/19/2013

WHITE PLAINS, N.Y., Feb. 19, 2013 /PRNewswire/ -- In 1964, the five-year survival rate for the most common form of childhood leukemia was only three percent but, today, thanks to treatment advances, about 90 percent of children survive. As the leading global non-profit organization dedicated to curing blood cancers, The Leukemia & Lymphoma Society (LLS) has invested nearly one billion dollars in blood cancer research since 1954, bringing us closer than ever to realizing a world without blood cancers.

(Photo:  http://photos.prnewswire.com/prnh/20130219/NY61444 )

LLS has achieved its leadership position through a unique approach to research and fundraising. Its venture philanthropy model forges partnerships with pharmaceutical and biotechnology companies, academia, medical centers and the National Institutes of Health, to foster the process of drug discovery from basic research to translational and clinical research. Rather than duplicate what the federal government is funding, LLS developed its own research agenda to accelerate the development of promising new life-saving therapies with a focus on un-met medical need.

"We're not your grandfather's charity," proclaims Louis DeGennaro , PhD, LLS chief mission officer. "There is no means of preventing or early screening for blood cancers, so our focus is on life-saving research to find cures. LLS research funding has touched the discovery or development of nearly every therapy used in the battle against blood cancers – including targeted drugs, like Gleevec®, Velcade® and Kyprolis™, and immunotherapies, like Rituxan®."

In fact, LLS is playing a unique role in the pathway to cures, especially for a non-profit organization.  Blood cancers, which include leukemia, lymphoma, myeloma and myelodysplastic syndromes, are hema
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
2. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
3. Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
4. Global Acute Myeloid Leukemia (AML) Therapeutics Industry
5. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
6. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
7. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
8. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
9. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
10. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
11. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 Having access to safe drinking ... battle in many corners of the globe. It’s a ... in northwestern Bolivia where many have been sickened by ... Fairfield University’s School of Engineering has been working to ... (UAC), “the united college for the peasants.” A branch ...
(Date:10/31/2014)... 2014 Caustic soda is utilized in the ... At present, China takes lead in the global caustic soda ... a number of facilities in the USA, Germany, Brazil and ... soda market in terms of output and production capacities. , ... average by 3% per year in the years ahead. The ...
(Date:10/31/2014)... IL (PRWEB) October 30, 2014 ... Insight Product Development’s decades-long heritage in successful medical ... world context for what it takes to successfully ... space. As part of a two-hour on-site class, ... Kellogg school of business, McCormick School of Engineering, ...
(Date:10/31/2014)... MA (PRWEB) October 30, 2014 ... Latin America were hosted by Charm Sciences at ... During their week in the US, the participants ... residue control, hygiene management, and process verification, and ... facility. , This was the first visit to ...
Breaking Biology Technology:Fairfield University School of Engineering project reduces illness in rural community 2Fairfield University School of Engineering project reduces illness in rural community 3China to Dominate Caustic Soda Market Through 2018, Says Merchant Research & Consulting in Its New Study 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Charm Sciences Hosts Executives from Latin America for Dairy Safety Executive Seminar 2
... are pleased to release the third in a ... , This third Podcast titled "Commercialization ... crucial issues around how nanotechnology can be taken ... commercial outcomes. , Dr Peter Binks, CEO of ...
... 7 Dendreon Corporation (Nasdaq:,DNDN) today announced that ... position of senior vice president of clinical affairs ... with over a decade of oncology,drug development and ... was instrumental to the filing of the company,s ...
... in the Department of Physics & Engineering ... with colleagues from the University of California, ... authored the article, High-frequency single-photon source with ... December 2007 issue of Nature Photonics ( ...
Cached Biology Technology:Commercialization of nanotechnology 2Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer 2Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer 3Professor Strauf's research is Nature Photonics’ cover article 2
(Date:10/31/2014)... live in Nuristan Province – some 60 years after ... glands are more valuable than gold , Study appears ... , NEW YORK (October 31, 2014) – More ... strange deer with vampire-like fangs still persists in the ... research team led by the Wildlife Conservation Society (WCS), ...
(Date:10/31/2014)... wide part of the electromagnetic spectrum from the infrared ... Sweden. The MAX IV facility presents a range of ... parts in a storage - ring synchrotron system that ... metres. Nevertheless, if these various challenges can be addressed ... source brightness and transverse coherence will be possible. ...
(Date:10/31/2014)... air out of a nagging mystery about the development of ... to why animal species didn,t flourish sooner, once sufficient oxygen ... end of the Proterozoic period, about 800 million years ago ... most researchers think there also was plenty of oxygen? , ... all. , In a study published Oct. 30 in ...
Breaking Biology News(10 mins):Strange, fanged deer persists in Afghanistan 2A new generation of storage -- ring 2Lack of oxygen delayed the rise of animals on Earth 2
... like cancer typically destroy nasty malignant cells, while ... in synthetic biology, researchers are designing molecules intelligent ... cells alone. "We basically design molecules that actually ... of the cellular state before delivering the therapeutic ...
... 1996 marked the beginning of a revolution in biological and ... by now the number of characterised species is approaching 1000, ... a few years away mapping the genetic evolution of ... able to identify the genetic causes of human disease and ...
... , A mutual epidemiological relationship between aggressive periodontitis and ... at the universities of Kiel, Dresden, Amsterdam and Bonn have ... on chromosome 9, which maps to a genetic region that ... latest edition of the specialist journal PLoS Genetics . ...
Cached Biology News:Engineers create intelligent molecules that seek-and-destroy diseased cells 2Engineers create intelligent molecules that seek-and-destroy diseased cells 3Genetic differences between yeasts greater than those between humans and chimpanzees 2
... EnzoLyte MG Phosphate Assay Kit is ... formed between Malachite Green, molybdate and free ... reaction can be conveniently measured on a ... reader. The non-radioactive colorimetric assay kits have ...
... The carbohydrate analysis standard is a ... a sugar alcohol; molecular weights range ... is provided for use with the ... analysis kit for column testing or ...
Metamine is an autonomous data mining tool that extends the capabilities of conventional research teams. It is a proactive agent that searches for significant results buried within the GeNet data rep...
... CAST Equine EIA Principle: ... LTD4 and LTE4 are products ... 5-lipoxygenase and glutathione-S-transferase. In the ... "Slow Reacting Substances of Anaphylaxis ...
Biology Products: